Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study

Joanne Reekie, Justyna D Kowalska, Igor Karpov, Jurgen Rockstroh, Anders Karlsson, Aza Rakhmanova, Andrzej Horban, Ole Kirk, Jens D Lundgren, Amanda Mocroft, EuroSIDA in EuroCoord, M Losso, C Elias, N Vetter, R Zangerle, I Karpov, A Vassilenko, V M Mitsura, O Suetnov, N Clumeck, S De Wit, M Delforge, R Colebunders, L Vandekerckhove, V Hadziosmanovic, K Kostov, J Begovac, L Machala, D Jilich, D Sedlacek, J Nielsen, G Kronborg, T Benfield, M Larsen, J Gerstoft, T Katzenstein, A-B E Hansen, P Skinhøj, C Pedersen, L Ostergaard, K Zilmer, Jelena Smidt, M Ristola, C Katlama, J-P Viard, P-M Girard, J M Livrozet, P Vanhems, C Pradier, F Dabis, D Neau, J Rockstroh, R Schmidt, J van Lunzen, O Degen, H J Stellbrink, S Staszewski, J Bogner, G Fätkenheuer, J Kosmidis, P Gargalianos, G Xylomenos, J Perdios, G Panos, A Filandras, E Karabatsaki, H Sambatakou, D Banhegyi, F Mulcahy, I Yust, D Turner, M Burke, S Pollack, G Hassoun, S Maayan, S Vella, R Esposito, I Mazeu, C Mussini, C Arici, R Pristera, F Mazzotta, A Gabbuti, V Vullo, M Lichtner, A Chirianni, E Montesarchio, M Gargiulo, G Antonucci, A Testa, P Narciso, C Vlassi, M Zaccarelli, A Lazzarin, A Castagna, N Gianotti, M Galli, A Ridolfo, A Monforte d'Arminio, B Rozentale, I Zeltina, S Chaplinskas, R Hemmer, T Staub, P Reiss, V Ormaasen, A Maeland, J Bruun, B Knysz, J Gasiorowski, A Horban, E Bakowska, A Grzeszczuk, R Flisiak, A Boron-Kaczmarska, M Pynka, M Parczewski, M Beniowski, E Mularska, H Trocha, E Jablonowska, E Malolepsza, K Wojcik, F Antunes, M Doroana, L Caldeira, K Mansinho, F Maltez, D Duiculescu, A Rakhmanova, N Zakharova, S Buzunova, D Jevtovic, M Mokráš, D Staneková, J Tomazic, J González-Lahoz, V Soriano, P Labarga, J Medrano, S Moreno, J M Rodriguez, B Clotet, A Jou, R Paredes, C Tural, J Puig, I Bravo, J M Gatell, J M Miró, P Domingo, M Gutierrez, G Mateo, M A Sambeat, A Karlsson, L Flamholc, B Ledergerber, R Weber, P Francioli, M Cavassini, B Hirschel, E Boffi, H Furrer, M Battegay, L Elzi, E Kravchenko, N Chentsova, V Frolov, G Kutsyna, S Servitskiy, M Krasnov, S Barton, A M Johnson, D Mercey, A Phillips, M A Johnson, A Mocroft, M Murphy, J Weber, G Scullard, M Fisher, C Leen, J Gatell, B Gazzard, A Horban, J Lundgren, I Karpov, B Ledergerber, M Losso, A D'Arminio Monforte, C Pedersen, A Phillips, A Rakhmanova, M Ristola, P Reiss, J Rockstroh, S De Wit, O Kirk, A Mocroft, A Cozzi-Lepri, D Grint, M Ellefson, D Podlekareva, J Kjær, L Peters, J Reekie, J Kowalska, J Nielsen, J Tverland, A H Fischer, O Kirk, A Mocroft, J Grarup, S deWitt, P Reiss, A Cozzi-Lepri, R Thiebaut, J Rockstroh, D Burger, R Paredes, J Kjær, Joanne Reekie, Justyna D Kowalska, Igor Karpov, Jurgen Rockstroh, Anders Karlsson, Aza Rakhmanova, Andrzej Horban, Ole Kirk, Jens D Lundgren, Amanda Mocroft, EuroSIDA in EuroCoord, M Losso, C Elias, N Vetter, R Zangerle, I Karpov, A Vassilenko, V M Mitsura, O Suetnov, N Clumeck, S De Wit, M Delforge, R Colebunders, L Vandekerckhove, V Hadziosmanovic, K Kostov, J Begovac, L Machala, D Jilich, D Sedlacek, J Nielsen, G Kronborg, T Benfield, M Larsen, J Gerstoft, T Katzenstein, A-B E Hansen, P Skinhøj, C Pedersen, L Ostergaard, K Zilmer, Jelena Smidt, M Ristola, C Katlama, J-P Viard, P-M Girard, J M Livrozet, P Vanhems, C Pradier, F Dabis, D Neau, J Rockstroh, R Schmidt, J van Lunzen, O Degen, H J Stellbrink, S Staszewski, J Bogner, G Fätkenheuer, J Kosmidis, P Gargalianos, G Xylomenos, J Perdios, G Panos, A Filandras, E Karabatsaki, H Sambatakou, D Banhegyi, F Mulcahy, I Yust, D Turner, M Burke, S Pollack, G Hassoun, S Maayan, S Vella, R Esposito, I Mazeu, C Mussini, C Arici, R Pristera, F Mazzotta, A Gabbuti, V Vullo, M Lichtner, A Chirianni, E Montesarchio, M Gargiulo, G Antonucci, A Testa, P Narciso, C Vlassi, M Zaccarelli, A Lazzarin, A Castagna, N Gianotti, M Galli, A Ridolfo, A Monforte d'Arminio, B Rozentale, I Zeltina, S Chaplinskas, R Hemmer, T Staub, P Reiss, V Ormaasen, A Maeland, J Bruun, B Knysz, J Gasiorowski, A Horban, E Bakowska, A Grzeszczuk, R Flisiak, A Boron-Kaczmarska, M Pynka, M Parczewski, M Beniowski, E Mularska, H Trocha, E Jablonowska, E Malolepsza, K Wojcik, F Antunes, M Doroana, L Caldeira, K Mansinho, F Maltez, D Duiculescu, A Rakhmanova, N Zakharova, S Buzunova, D Jevtovic, M Mokráš, D Staneková, J Tomazic, J González-Lahoz, V Soriano, P Labarga, J Medrano, S Moreno, J M Rodriguez, B Clotet, A Jou, R Paredes, C Tural, J Puig, I Bravo, J M Gatell, J M Miró, P Domingo, M Gutierrez, G Mateo, M A Sambeat, A Karlsson, L Flamholc, B Ledergerber, R Weber, P Francioli, M Cavassini, B Hirschel, E Boffi, H Furrer, M Battegay, L Elzi, E Kravchenko, N Chentsova, V Frolov, G Kutsyna, S Servitskiy, M Krasnov, S Barton, A M Johnson, D Mercey, A Phillips, M A Johnson, A Mocroft, M Murphy, J Weber, G Scullard, M Fisher, C Leen, J Gatell, B Gazzard, A Horban, J Lundgren, I Karpov, B Ledergerber, M Losso, A D'Arminio Monforte, C Pedersen, A Phillips, A Rakhmanova, M Ristola, P Reiss, J Rockstroh, S De Wit, O Kirk, A Mocroft, A Cozzi-Lepri, D Grint, M Ellefson, D Podlekareva, J Kjær, L Peters, J Reekie, J Kowalska, J Nielsen, J Tverland, A H Fischer, O Kirk, A Mocroft, J Grarup, S deWitt, P Reiss, A Cozzi-Lepri, R Thiebaut, J Rockstroh, D Burger, R Paredes, J Kjær

Abstract

Background: Differences in access to care and treatment have been reported in Eastern Europe, a region with one of the fastest growing HIV epidemics, compared to the rest of Europe. This analysis aimed to establish whether there are regional differences in the mortality rate of HIV-positive individuals across Europe, and Argentina.

Methods: 13,310 individuals under follow-up were included in the analysis. Poisson regression investigated factors associated with the risk of death.

Findings: During 82,212 person years of follow-up (PYFU) 1,147 individuals died (mortality rate 14.0 per 1,000 PYFU (95% confidence interval [CI] 13.1-14.8). Significant differences between regions were seen in the rate of all-cause, AIDS and non-AIDS related mortality (global p<0.0001 for all three endpoints). Compared to South Europe, after adjusting for baseline demographics, laboratory measurements and treatment, a higher rate of AIDS related mortality was observed in East Europe (IRR 2.90, 95%CI 1.97-4.28, p<.0001), and a higher rate of non-AIDS related mortality in North Europe (IRR 1.51, 95%CI 1.24-1.82, p<.0001). The differences observed in North Europe decreased over calendar-time, in 2009-2011, the higher rate of non-AIDS related mortality was no longer significantly different to South Europe (IRR 1.07, 95%CI 0.66-1.75, p = 0.77). However, in 2009-2011, there remained a higher rate of AIDS-related mortality (IRR 2.41, 95%CI 1.11-5.25, p = 0.02) in East Europe compared to South Europe in adjusted analysis.

Interpretations: There are significant differences in the rate of all-cause mortality among HIV-positive individuals across different regions of Europe and Argentina. Individuals in Eastern Europe had an increased risk of mortality from AIDS related causes and individuals in North Europe had the highest rate of non-AIDS related mortality. These findings are important for understanding and reviewing HIV treatment strategies and policies across the European region.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Crude mortality rate across the…
Figure 1. Crude mortality rate across the six different regions.
Cause of death are reported by the site investigator and, since 2004, a Coding of Death in HIV (CoDe) case report form is additionally completed for each fatal case and CoDe methods used to determine the underlying cause of death.
Figure 2. Incidence rate ratio (IRR) for…
Figure 2. Incidence rate ratio (IRR) for all cause, AIDS and non-AIDS related mortality per calendar year of follow-up stratified by region.
(Argentina was excluded from this analysis due to limited power). aadjusted for gender, age*, HIV exposure group, hepatitis B* and C* status, prior AIDS diagnosis, prior non-AIDS diagnosis, hypertension*, diabetes*, anaemia*, smoking status*, CD4 count*, baseline date* and on cART viral load*. badjusted for gender, age*, HIV exposure group, hepatitis B* and C* status, prior AIDS diagnosis, prior non-AIDS diagnosis, hypertension*, diabetes*, anaemia*, CD4 count*, baseline date* and on cART viral load*. *time-updated.

References

    1. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–299.
    1. Lewden C, May T, Rosenthal E, Burty C, Bonnet F, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48:590–598.
    1. Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663–1671.
    1. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:a3172.
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS) Fact Sheet, North America and Western and Central Europe. Latest epidemiological trends. 2009.
    1. UNAIDS, World Health Organization. 09 AIDS epidemic update. 2009. pp. 1–100.
    1. Podlekareva D, Reekie J, Rakhmanova A, Horban A, Mocroft A, et al. Indicators of the use of healthcare interventions across Europe. 2008.
    1. Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, et al. The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe–a review of published results. Cent Eur J Public Health. 2008;16:99–105.
    1. Chiesi A, Mocroft A, Dally LG, Miller V, Katlama C, et al. Regional survival differences across Europe in HIV-positive people: the EuroSIDA study. AIDS. 1999;13:2281–2288.
    1. UNAIDS. Argentina County Sitution 2009. 2009.
    1. Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, et al. Loss to follow-up in an international, multicentre observational study. HIV Med. 2008;9:261–269.
    1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22–29.
    1. Kowalska JD, Friis-Moller N, Kirk O, Bannister W, Mocroft A, et al. The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology. 2011;22:516–523.
    1. Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, et al. A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study. HIV Clin Trials. 2011;12:109–117.
    1. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS. 1999;13:943–950.
    1. UNAIDS. Global Report:UNAIDS report on the global AIDS epidmic. 2010.
    1. UNAIDS. Fact sheets. Eastern Europe and Central Asia. Latest epidemiological trends. 2009.
    1. van Asten LC, Boufassa F, Schiffer V, Brettle RP, Robertson JR, et al. Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level. Eur J Public Health. 2003;13:347–349.
    1. Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, et al. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ. 2003;169:656–661.
    1. Braitstein P, Justice A, Bangsberg DR, Yip B, Alfonso V, et al. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS 20: 323–331. 10.1097/01.aids.0000198091.70325.f4 [doi];00002030-200602140-00003 [pii] 2006.
    1. Murray M, Hogg R, Lima V, May M, Moore D, et al. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Med. 10.1111/j.1468-1293.2011.00940.x [doi] 2011.
    1. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 375: 1014–1028. S0140-6736(10)60232-2 [pii];10.1016/S0140-6736(10)60232-2 [doi] 2010.
    1. Sarang A, Rhodes T, Platt L. Access to syringes in three Russian cities: implications for syringe distribution and coverage. Int J Drug Policy 19 Suppl 1: S25–S36. S0955-3959(07)00244-7 [pii];10.1016/j.drugpo.2007.11.008 [doi] 2008.
    1. Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet 361: 1035–1044. S0140-6736(03)12831-0 [pii];10.1016/S0140-6736(03)12831-0 [doi] 2003.
    1. Friis-Moller N, Sabin CA, Weber R, d’Arminio MA, El-Sadr WM, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993–2003.
    1. Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121–130.
    1. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008;337:a1344.
    1. Vollset SE. Does the southern European cardiovascular mortality advantage extend to total mortality? 50-year trends in death risks between 40 and 70 years of age in Western European men and women. Scand J Public Health. 2010;38:127–134.
    1. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141–155.
    1. UNAIDS. 08 Report on the global AIDS epidemic. 2008.

Source: PubMed

3
Abonnere